BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25727999)

  • 1. Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty.
    Yi SH; Baggs J; Culler SD; Berríos-Torres SI; Jernigan JA
    J Arthroplasty; 2015 Jun; 30(6):931-8.e2. PubMed ID: 25727999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Stage Periprosthetic Joint Infection Reimbursement-Is It Worth The Effort?
    Fehring KA; Curtin BM; Springer BD; Fehring TK
    J Arthroplasty; 2019 Sep; 34(9):2072-2074. PubMed ID: 31155461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Analysis of 4221 Revisions Due to Periprosthetic Joint Infection in Poland.
    Babiak I; Pędzisz P; Janowicz J; Kulig M; Małdyk P
    Ortop Traumatol Rehabil; 2017 Jan; 19(1):33-44. PubMed ID: 28436379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of Treatment Duration in Periprosthetic Infection with a Fast-Track Concept Is Economically Not Feasible].
    Lieb E; Hanstein T; Schuerings M; Trampuz A; Perka C
    Z Orthop Unfall; 2015 Dec; 153(6):618-23. PubMed ID: 26468925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection.
    Kamath AF; Ong KL; Lau E; Chan V; Vail TP; Rubash HE; Berry DJ; Bozic KJ
    J Arthroplasty; 2015 Sep; 30(9):1492-7. PubMed ID: 25865815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial Analysis of Treating Periprosthetic Joint Infections at a Tertiary Referral Center.
    Waddell BS; Briski DC; Meyer MS; Ochsner JL; Chimento GF
    J Arthroplasty; 2016 May; 31(5):952-6. PubMed ID: 26703194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Reimbursement for Total Joint Arthroplasty: The Driving Forces.
    Padegimas EM; Verma K; Zmistowski B; Rothman RH; Purtill JJ; Howley M
    J Bone Joint Surg Am; 2016 Jun; 98(12):1007-13. PubMed ID: 27307361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare Population.
    Kurtz SM; Lau EC; Son MS; Chang ET; Zimmerli W; Parvizi J
    J Arthroplasty; 2018 Oct; 33(10):3238-3245. PubMed ID: 29914821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The High Value Healthcare Collaborative: Observational Analyses of Care Episodes for Hip and Knee Arthroplasty Surgery.
    Weeks WB; Schoellkopf WJ; Sorensen LS; Masica AL; Nesse RE; Weinstein JN
    J Arthroplasty; 2017 Mar; 32(3):702-708. PubMed ID: 27776908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Prosthetic Joint Infection Increases Following Early Aseptic Revision Surgery of Total Hip and Knee Arthroplasty.
    Quinlan ND; Werner BC; Brown TE; Browne JA
    J Arthroplasty; 2020 Dec; 35(12):3661-3667. PubMed ID: 32712119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of Medicare trends in utilization and hospital economics for total knee and hip arthroplasty from 2005 to 2011.
    Nwachukwu BU; McCormick F; Provencher MT; Roche M; Rubash HE
    J Arthroplasty; 2015 Jan; 30(1):15-8. PubMed ID: 25267535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic Analysis of the Costs of Hospital Stay of Patients with Infection as a Complication of Total Replacements - Part 1: Total Knee Arthroplasty].
    Musil D; Šnorek M; Gallo J; Jahoda D; Stehlík J
    Acta Chir Orthop Traumatol Cech; 2019; 86(3):173-180. PubMed ID: 31333180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic Analysis of the Costs of Hospital Stay of Patients with Infection as a Complication of Total Replacements - Part 2: Total Hip Arthroplasty].
    Musil D; Šnorek M; Gallo J; Jahoda D; Stehlík J
    Acta Chir Orthop Traumatol Cech; 2019; 86(4):241-248. PubMed ID: 31524584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Hospital Mortality in Patients With Periprosthetic Joint Infection.
    Shahi A; Tan TL; Chen AF; Maltenfort MG; Parvizi J
    J Arthroplasty; 2017 Mar; 32(3):948-952.e1. PubMed ID: 27816369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Periprosthetic Hip Infection and Associated Costs: A Population-Based Study Assessing the Impact of Hospital Factors Using National Data.
    Brochin RL; Phan K; Poeran J; Zubizarreta N; Galatz LM; Moucha CS
    J Arthroplasty; 2018 Jul; 33(7S):S233-S238. PubMed ID: 29573912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprosthetic Infection Recurrence After 2-Stage Exchange Arthroplasty: Failure or Fate?
    Triantafyllopoulos GK; Memtsoudis SG; Zhang W; Ma Y; Sculco TP; Poultsides LA
    J Arthroplasty; 2017 Feb; 32(2):526-531. PubMed ID: 27646832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Hospital Costs per Case of Periprosthetic Hip and Knee Joint Infections in Europe - A Systematic Review.
    Szymski D; Walter N; Hierl K; Rupp M; Alt V
    J Arthroplasty; 2024 Jul; 39(7):1876-1881. PubMed ID: 38266688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States.
    Premkumar A; Kolin DA; Farley KX; Wilson JM; McLawhorn AS; Cross MB; Sculco PK
    J Arthroplasty; 2021 May; 36(5):1484-1489.e3. PubMed ID: 33422392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare fails to compensate additional surgical time and effort associated with revision arthroplasty.
    Tokarski AT; Deirmengian CA; Lichstein PM; Austin MS; Deirmengian GK
    J Arthroplasty; 2015 Apr; 30(4):535-8. PubMed ID: 25468783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.